Tag:
Kenneth Frazier
Latest Headlines
Latest Headlines
Merck CEO assures shareholders there is life after death of Singulair patent
With its $5.5 billion seller Singulair going off patent in two months, things will be a little dicey for the next couple of years at Merck.
Merck CEO Frazier: "The future of the industry is going to be more partnerships"
Merck ( $MRK ) CEO Kenneth Frazier is deploying his deal team this year with some very specific instructions to step up their game. Speaking to an investor group, the CEO made it clear that the pharma
Merck chief defends $8B R&D budget as vital long-term investment
One of the biggest debates in Big Pharma right now revolves around whether execs should be chopping back their multibillion-dollar R&D budgets as they attempt to reinvent the whole pipeline
Clark exits Merck Dec. 1, passing chairman title to CEO
Merck ( $MRK ) Chairman Richard Clark ( photo ) will retire Dec. 1, leaving Kenneth Frazier ( photo ) with the dual role of chairman and CEO. Frazier took the operational reins at Merck in January after
Merck chief stands by his big R&D spend
Don't expect Merck CEO Ken Frazier to offer any apologies for the company's big R&D budget. "Science and innovation are in the DNA of the company," he told reporters for the Wall Street Journal.
Merck chief concerned over future U.S. biopharma innovation
Merck ($MRK) CEO Kenneth Frazier has weighed in on some of the U.S. biopharmaceutical industry's most pressing issues in an opinion piece in the Wall Street Journal. He warns that weak protections on
Merck chief's pay rose more than 50% to $24.6M
Color Richard Clark ( photo ) happy. Merck's former CEO (and current chairman) collected a bigger pay envelope last year--his final one as chief executive. The pay hike was either 55 percent or 65
Merck traded earnings targets for freedom, flexibility
You could say Merck just didn't want to be tied down. When the company pulled its long-term profit goals last month, CEO Kenneth Frazier ( photo ) caught a lot of flak from analysts, but he defended
New Merck chief hints at emerging-markets pricing
Merck's ($MRK) incoming CEO Kenneth Frazier ( photo ) is promising new innovation and continued focus on emerging-markets growth. No surprises there: Merck is just one of the Big Pharma crowd that
Merck ($MRK) to ring in 2011 with Frazier as CEO
New year, new top executive. Merck's ( $MRK ) 55-year-old President Kenneth Frazier ( photo ) will ascend to the CEO's office effective January 1. That's a couple of months before company policy would
